Pembrolizumab-induced Autoimmune Hemolytic Anemia and Hemophagocytic Lymphohistiocytosis in Non-small Cell Lung Cancer

We herein report a 78-year old man with squamous cell carcinoma of the lungs treated with pembrolizumab. At 10 days after the administration of pembrolizumab, he showed progressive anemia and increased levels of bilirubin. Because the findings of a direct coombs test and cold hemagglutinin were posi...

Descripción completa

Detalles Bibliográficos
Autores principales: Okawa, Sachi, Kayatani, Hiroe, Fujiwara, Keiichi, Ozeki, Taichi, Takada, Kenji, Iwamoto, Yoshitaka, Minami, Daisuke, Sato, Ken, Shibayama, Takuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443545/
https://www.ncbi.nlm.nih.gov/pubmed/30828042
http://dx.doi.org/10.2169/internalmedicine.1001-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443545/
https://www.ncbi.nlm.nih.gov/pubmed/30828042
http://dx.doi.org/10.2169/internalmedicine.1001-18

Ejemplares similares